Alm Soravis Osataphan, MD
@alm_o
GI oncologist focusing on cholangiocarcinoma and neuroendocrine tumors @BIDMChealth & @HarvardMed. Views are my own. #GIOncology #Cholangiocarcinoma #Metabolism
Just in from @NEJM - Our case report on the use of anti-insulin receptor antibodies as a novel strategy to tackle refractory hypoglycemia and malignant insulinoma! Immensely grateful to my mentors ME Patti and Ahmed Rattani and the ICU & endocrine team @BIDMChealth as well as the…



Thank you @Erman_Akkus for highlighting our MTAP study. Notably, we did not find association between OS & CDKN2A/B loss when MTAP was intact – raising an importance ❓ if CDKN2A/B mutations are bystanders and the biological roles of these 3 proteins in CCA progression @curecc
🧬MTAP loss in cholangiocarcinoma @JCOPO_ASCO ➡️Frequency: 16% 🚨Worse OS HR: 3.95 [1.43 to 10.9]; P = .008 ❗️An actionable target 👉ascopubs.org/doi/10.1200/PO… #cancer #oncology #biliary #MedX @OncoAlert @PrecisionBTCnet @curecc
Immensely proud of and grateful for this village! We gathered to celebrate intelligence, integrity, curiosity, and compassion. Congratulations to our graduating @BIDMC_HOFellows and thank you to our BIDMC Heme/Onc family. May your stars shine bright always!
Wrapped up heme/onc fellowship today —grateful and excited to stay on as a GI oncology attending at @BIDMChealth ! Sincere thanks to @DeepaRangachari and @rushadpatell for your wise counsel, impactful mentorship and unwavering support throughout the journey. 🙏🙏🙏…

“Not everything that counts can be counted. Not everything that can be counted, counts.” -@marklewismd In oncology, metrics matter. But meaning or time or values? You can’t quantify those. That’s why shared decision-making isn’t just a buzzword; it’s the ENTIRE point. #ASCO25
The remarkable benefit of exercise was just extended to improved survival after cancer in a randomized trial @NEJM #ASCO25 nejm.org/doi/full/10.10…
Thank you @melinda_bachini and @curecc for supporting my @ASCO YIA application and @ConquerCancerFd for funding our study to advance the understanding of cholangiocarcinoma tumor microenvironment. Incredibly grateful for the mentorship from the BI team ML peters, @ioavlachos and…




@BIDMC_CancerCtr and @BIDMC_HOFellows are elated and proud to celebrate our very own senior fellow Dr. @alm_o for this incredibly well deserved recognition— may your curiosity and innovation continue to soar and lead us to new heights! @rushadpatell #ASCO25
Congratulations to this year’s class of Conquer Cancer grant and award recipients! Are you one of them? Tell us in the comments! We can't wait to celebrate with you at #ASCO25. Full list of recipients: brnw.ch/21wSR0A @ASCO
Go here to sign the petition to #ShutDownMASS in order to minimize the spread of #coronavirus at Change.org change.org/p/massachusett…